We are live on ! Find out more
ARTLW

Artelo Biosciences, Inc. Warrant

Delisted

ARTLW was delisted on the 17th of June, 2024.

5 hedge funds and large institutions have $15K invested in Artelo Biosciences, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 45 (+1)

12% less capital invested

Capital invested by funds: $17K → $15K (-$2K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.01K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$55
Name Holding Trade Value Shares
Change
Change in
Stake
Verition Fund Management
1
Verition Fund Management
Connecticut
$8K
AGM
2
Alpine Global Management
New York
$3K
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$3K +$4.01K +13,786 New
UBS Group
4
UBS Group
Switzerland
$1K -$55 -190 -4%

ARTLW Hedge Fund Activity: Q3 2021 in Review

5 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q3 2021, worth a combined $15K — down 12% from $17K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ARTLW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $4.01K. The largest seller was UBS Group, cutting an estimated $55.

  • 5 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q3 2021, up from 4 in Q2 2021.
  • Funds reported $15K of Artelo Biosciences, Inc. Warrant stock for Q3 2021, down 12% quarter-over-quarter.
  • 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q3 2021 and 0 closed out, a net change of +1 holder.
  • The largest Artelo Biosciences, Inc. Warrant buyer in Q3 2021 was Susquehanna International Group, an estimated $4.01K added.
  • The largest Artelo Biosciences, Inc. Warrant seller in Q3 2021 was UBS Group, an estimated $55 sold.

Based on aggregated 13F filings for Q3 2021.